L. A. Silverman

A 4-year, Open-label, Multicenter, Randomized Trial of Genotropin Growth Hormone in Patients with Idiopathic Short Stature: Analysis of 4-year Data Comparing Efficacy, Efficiency, and Safety between an Individualized, Target-driven Regimen and Standard Dosing Key Words Cost Effectiveness · Clinical

M. Geffner, L. Levitsky, D. Counts, 2022 .

Personalized Approach to Growth Hormone Treatment: Clinical Use of Growth Prediction Models

S. van Buuren, P. Clayton, J. Wit, 2013, Hormone Research in Paediatrics.